Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€4.66
12.12.21
-
12.12.22
-1.27%
25.12.21

Could be worthwhile Investment >10% per year
buy
Puma Biotechnology Inc.

Start price
Target price
Perf. (%)
€2.48
12.12.21
-
12.12.22
25.48%
25.12.21

Could be worthwhile Investment >10% per year
buy
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€2.49
12.12.21
-
12.12.22
4.74%
25.12.21

Could be worthwhile Investment >10% per year
buy
Cytomx Therapeutics Inc

Start price
Target price
Perf. (%)
€3.49
21.12.21
-
21.12.22
7.56%
25.12.21

Risky Investment
buy
Myovant Sciences Ltd

Start price
Target price
Perf. (%)
€12.89
12.12.21
-
12.12.22
7.45%
25.12.21

Could be worthwhile Investment >10% per year
buy
Radius Health Inc.

Start price
Target price
Perf. (%)
€6.70
12.12.21
-
12.12.22
-5.19%
25.12.21

Could be worthwhile Investment >10% per year
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€14.95
12.12.21
-
12.12.22
1.10%
25.12.21

Could be worthwhile Investment >10% per year
buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€32.60
16.12.21
-
16.12.22
38.19%
25.12.21

Could be worthwhile Investment >10% per year
buy
Valneva SE

Start price
Target price
Perf. (%)
€23.36
11.12.21
€30.00
11.12.22
8.73%
25.12.21

Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
buy
Formycon AG

Start price
Target price
Perf. (%)
€66.90
18.04.21
-
18.04.22
-16.59%
21.12.21

Could be worthwhile Investment >10% per year
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€16.08
24.06.21
€4.80
24.06.22
-60.12%
20.12.21

Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
CytoDyn Inc_INT

Start price
Target price
Perf. (%)
€1.28
10.07.21
€0.80
10.07.22
-30.80%
20.12.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
buy
Xenon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€14.20
18.09.21
€40.00
31.12.23
61.97%
16.12.21

Could be very worthwhile Investment >20% year
Oramed Pharmaceuticals

Start price
Target price
Perf. (%)
€23.30
04.11.21
€10.00
04.11.23
-42.83%
16.12.21

Could be very worthwhile Investment >20% year
Valneva SE

Start price
Target price
Perf. (%)
€12.34
13.09.21
€9.00
13.09.22
100.65%
16.12.21

Could be very worthwhile Investment >20% year
buy
Aptose Biosciences

Start price
Target price
Perf. (%)
€3.22
11.06.21
€4.00
11.06.22
-69.57%
14.12.21

Could be worthwhile Investment >10% per year
buy
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€16.95
11.11.21
€30.00
11.11.22
-21.68%
14.12.21

Could be worthwhile Investment >10% per year
buy
Nanostr.technol.

Start price
Target price
Perf. (%)
€57.50
13.12.20
-
13.12.21
-41.91%
14.12.21

Risky Investment
PhaseBio Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€3.60
12.12.20
-
12.12.21
-42.22%
13.12.21

Probably not worthwhile Investment
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€14.88
05.12.21
-
05.12.22
0.47%
12.12.21

Risky Investment
buy
Radius Health Inc.

Start price
Target price
Perf. (%)
€7.05
08.12.21
-
08.12.22
-4.99%
12.12.21

Risky Investment
buy
Fennec Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€4.22
29.11.21
-
29.11.22
-16.11%
12.12.21

Could be worthwhile Investment >10% per year
InMed Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€39.25
30.11.21
-
30.11.22
-17.83%
12.12.21

Probably not worthwhile Investment
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€17.00
28.11.21
-
28.11.22
7.65%
11.12.21

Could be worthwhile Investment >10% per year
buy
Myovant Sciences Ltd

Start price
Target price
Perf. (%)
€14.52
01.12.21
-
01.12.22
-11.23%
11.12.21

Could be very worthwhile Investment >20% year